drugset / Trial / NCT04181008

Pharmacokinetics of Amiloride Nasal Spray in Healthy Volunteers

NCT04181008

RandomizedSingle-groupOpen-labelBasic science

Summary

This study is a single-center, open-label study of the plasma pharmacokinetics of amiloride nasal spray at three different doses in healthy volunteers.

Timeline

Start
2020-09-28
Primary completion
2022-08-30
Completion
2023-03-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amiloride Small molecule 0.2 mg Intranasal
Subject Amiloride Small molecule 0.4 mg Intranasal
Subject Amiloride Small molecule 0.6 mg Intranasal

Indications

No indication recorded.